Occurrence of Dermatomyositis Immediately after Mastectomy Subsequent to Severe Chemotherapeutic Drug Eruption

Intern Med. 2017;56(24):3379-3383. doi: 10.2169/internalmedicine.9194-17. Epub 2017 Dec 15.

Abstract

We herein report a patient with breast cancer who developed dermatomyositis (DM) immediately after mastectomy. She had a history of severe drug eruption during neoadjuvant chemotherapy six months previously. Within a month after the operation, myalgia and rash, including Gottron's papules, developed, and skeletal-muscle enzymes elevated, so she was diagnosed with probable DM according to the Bohan and Peter criteria. In many neoplastic DM cases, the course of the disease parallels the course of the malignancy. Possible mechanisms were suggested to explain the development of DM in the present case and offer new insight into autoimmune diseases.

Keywords: chemotherapy; paraneoplastic dermatomyositis; severe drug eruption; surgery.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Asian People
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / surgery*
  • Dermatomyositis / chemically induced*
  • Drug Eruptions / etiology*
  • Female
  • Humans
  • Mastectomy / adverse effects*
  • Middle Aged
  • Treatment Outcome

Substances

  • Antineoplastic Agents